论文信息 - Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. - 字舞流文

Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.

B. P. Doctor | Wei Sun | A. Saxena | C. Luo

[1] Y. Ashani. Prospective of human butyrylcholinesterase as a detoxifying antidote and potential regulator of controlled‐release drugs , 2000 .

[2] Y. Ashani,et al. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[3] Y. Ashani,et al. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. , 1997, Toxicology and applied pharmacology.

[4] P B Laub,et al. NCOMP--a windows-based computer program for noncompartmental analysis of pharmacokinetic data. , 1996, Journal of pharmaceutical sciences.

[5] Y. Ashani,et al. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. , 1993, Biochemical pharmacology.

[6] F. Sidell,et al. Progress in medical defense against nerve agents. , 1989, JAMA.

[7] C. McLeod. Pathology of nerve agents: perspectives on medical management. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[8] P. DIRNHUBER,et al. The protection of primates against soman poisoning by pretreatment with pyridostigmine , 1979, The Journal of pharmacy and pharmacology.

[9] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.